UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 382

Sortiert nach

Hepatocellular carcinoma in the Asia pacific region

Journal of gastroenterology and hepatology, 2009-03, Vol.24 (3), p.346-353

2009

Link zum Volltext

Verfügbarkeit prüfen

Genome-scale profiling of circulating cell-free DNA signatures for early detection of hepatocellular carcinoma in cirrhotic patients

Cell research, 2021-05, Vol.31 (5), p.589-592

2021

Link zum Volltext

Verfügbarkeit prüfen

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

Hepatology international, 2012-06, Vol.6 (3), p.531-561

2012

Link zum Volltext

Verfügbarkeit prüfen

APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy

Hepatology international, 2021-10, Vol.15 (5), p.1031-1048

2021

Link zum Volltext

Verfügbarkeit prüfen

Chinese recommendations for clinical practice guideline development

Zhonghua gan zang bing za zhi, 2015-12, Vol.23 (12), p.881

2015

Link zum Volltext

Verfügbarkeit prüfen

Stepwise application of fibrosis index based on four factors, red cell distribution width-platelet ratio, and aspartate aminotransferase-platelet ratio for compensated hepatitis B fibrosis detection

Journal of gastroenterology and hepatology, 2018-01, Vol.33 (1), p.256-263

2018

Link zum Volltext

Verfügbarkeit prüfen

The guideline of prevention and treatment for chronic hepatitis B: a 2015 update

Zhonghua gan zang bing za zhi, 2015-12, Vol.23 (12), p.888

2015

Link zum Volltext

Verfügbarkeit prüfen

Current Strategies for Quantitating Fibrosis in Liver Biopsy

Chinese medical journal, 2015-01, Vol.128 (2), p.252-258

2015

Link zum Volltext

Verfügbarkeit prüfen

First line nucleos(t)ide analog monotherapy is more cost-effective than combination strategies in hepatitis B e antigen-positive chronic hepatitis B patients in China

Chinese medical journal, 2019-10, Vol.132 (19), p.2315-2324

2019

Link zum Volltext

Verfügbarkeit prüfen

Current understanding of the pathogenic mechanisms of HBsAg and their impact on clinical management of hepatitis B

Zhonghua gan zang bing za zhi, 2013-07, Vol.21 (7), p.491

2013

Link zum Volltext

Verfügbarkeit prüfen

A recombinant adenovirus vector carrying murine interleukin-21 gene controls chronic HBV infection in mice

Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2017-11, Vol.37 (11), p.1436

2017

Link zum Volltext

Verfügbarkeit prüfen

Persistent attention on chronic hepatitis B clinical study

Zhonghua gan zang bing za zhi, 2013-03, Vol.21 (3), p.161

2013

Link zum Volltext

Verfügbarkeit prüfen

Individualized treatment strategies for chronic hepatitis B

Chung-hua nei kʿo tsa chih, 2012-10, Vol.51 (10), p.746

2012

Link zum Volltext

Verfügbarkeit prüfen

Characteristics of lymphocyte phenotypes in HBV transgenic mice and the effect of interferon-α: a preliminary study

Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2016-06, Vol.36 (6), p.870

2016

Link zum Volltext

Verfügbarkeit prüfen

Self-roughened superhydrophobic coatings for continuous oil–water separation

Journal of materials chemistry. A, Materials for energy and sustainability, 2015-05, Vol.3 (19), p.10248-10253

2015

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 Countries

Clinical gastroenterology and hepatology, 2020-02, Vol.18 (2), p.457-467.e21

2020

Link zum Volltext

Verfügbarkeit prüfen

Genotype B and Younger Patient Age Associated with Better Response to Low-Dose Therapy: A Trial with Pegylated/Nonpegylated Interferon-α-2b for Hepatitis B e Antigen—Positive Patients with Chronic Hepatitis B in China

Clinical infectious diseases, 2007-02, Vol.44 (4), p.541-548

2007

Link zum Volltext

Verfügbarkeit prüfen

The guideline of prevention and treatment for hepatitis C: a 2015 update

Zhonghua gan zang bing za zhi, 2015-12, Vol.23 (12), p.906

2015

Link zum Volltext

Verfügbarkeit prüfen

Hepatocellular Carcinoma Risk Scores from Modeling to Real Clinical Practice in Areas Highly Endemic for Hepatitis B Infection

Journal of clinical and translational hepatology, 2023-12, Vol.11 (7), p.1508-1519

2023

Link zum Volltext

Verfügbarkeit prüfen

Pharmacoeconomic evaluation of telbivudine vs. lamivudine in treating the patients with HBeAg-positive and negative chronic hepatitis B

Zhonghua gan zang bing za zhi, 2009-08, Vol.17 (8), p.569

2009

Link zum Volltext

Verfügbarkeit prüfen

T Cell Responses to Whole SARS Coronavirus in Humans

The Journal of immunology (1950), 2008-10, Vol.181 (8), p.5490-5500

2008

Link zum Volltext

Verfügbarkeit prüfen

Genotype and mutation of hepatitis B virus and severe hepatitis

Zhonghua gan zang bing za zhi, 2010-02, Vol.18 (2), p.85

2010

Link zum Volltext

Verfügbarkeit prüfen

Complementarity-Determining Region 3 Size Spectratypes of T Cell Receptor β Chains in CD8+ T Cells following Antiviral Treatment of Chronic Hepatitis B

Antimicrobial Agents and Chemotherapy, 2011-02, Vol.55 (2), p.888-894

2011

Link zum Volltext

Verfügbarkeit prüfen

The Landscape of Cell-Free HBV Integrations and Mutations in Cirrhosis and Hepatocellular Carcinoma Patients

Clinical cancer research, 2021-07, Vol.27 (13), p.3772-3783

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 382

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(246)
Mit Volltextzugriff
(270)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(174)
Humans
(161)
Life Sciences & Biomedicine
(128)
Female
(87)
Male
(81)
Adult
(73)
Middle Aged
(59)
Hepatitis B Virus - Genetics
(41)
Gastroenterology & Hepatology
(33)
Hepatitis B, Chronic - Drug Therapy
(30)
Genotype
(29)
Technology
(29)
Animals
(28)
Hepatitis B, Chronic - Virology
(28)
Antiviral Agents - Therapeutic Use
(27)
Physical Sciences
(27)
Adolescent
(26)
Young Adult
(25)
Aged
(23)
Biological And Medical Sciences
(23)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Hepatocellular carcinoma in the Asia pacific region

Genome-scale profiling of circulating cell-free DNA signatures for early detection of hepatocellular carcinoma in cirrhotic patients

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy

Chinese recommendations for clinical practice guideline development

Stepwise application of fibrosis index based on four factors, red cell distribution width-platelet ratio, and aspartate aminotransferase-platelet ratio for compensated hepatitis B fibrosis detection

The guideline of prevention and treatment for chronic hepatitis B: a 2015 update

Current Strategies for Quantitating Fibrosis in Liver Biopsy

Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World Data

First line nucleos(t)ide analog monotherapy is more cost-effective than combination strategies in hepatitis B e antigen-positive chronic hepatitis B patients in China

Current understanding of the pathogenic mechanisms of HBsAg and their impact on clinical management of hepatitis B

A recombinant adenovirus vector carrying murine interleukin-21 gene controls chronic HBV infection in mice

Persistent attention on chronic hepatitis B clinical study

Individualized treatment strategies for chronic hepatitis B

Characteristics of lymphocyte phenotypes in HBV transgenic mice and the effect of interferon-α: a preliminary study

Self-roughened superhydrophobic coatings for continuous oil–water separation

Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 Countries

Genotype B and Younger Patient Age Associated with Better Response to Low-Dose Therapy: A Trial with Pegylated/Nonpegylated Interferon-α-2b for Hepatitis B e Antigen—Positive Patients with Chronic Hepatitis B in China

The guideline of prevention and treatment for hepatitis C: a 2015 update

Hepatocellular Carcinoma Risk Scores from Modeling to Real Clinical Practice in Areas Highly Endemic for Hepatitis B Infection

Pharmacoeconomic evaluation of telbivudine vs. lamivudine in treating the patients with HBeAg-positive and negative chronic hepatitis B

T Cell Responses to Whole SARS Coronavirus in Humans

Genotype and mutation of hepatitis B virus and severe hepatitis

Complementarity-Determining Region 3 Size Spectratypes of T Cell Receptor β Chains in CD8+ T Cells following Antiviral Treatment of Chronic Hepatitis B

The Landscape of Cell-Free HBV Integrations and Mutations in Cirrhosis and Hepatocellular Carcinoma Patients

Suchergebnisse filtern